Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects
NCT00808119
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Cocaine Dependence
Interventions
DRUG:
RTI-336 (CTDP 31862)
Sponsor
RTI International
Collaborators
[object Object]